GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Currency in USD	2025
Operating Income	2.76 Billion
Income Before Tax	2.77 Billion
Income Tax Expense	614.00 Million
Net Income	2.08 Billion
Eps	4.56
Epsdiluted	4.55
Weighted Average Shs Out	456.00 Million
Weighted Average Shs Out Dil	458.00 Million
Research And Development Expenses	1.26 Billion
Selling General And Administrative Expenses	4.22 Billion
Depreciation And Amortization	578.00 Million
Interest Expense	440.00 Million
Interest Income	41.00 Million
Net Interest Income	-399 Million
Premiums Earned	N/A
Policyholder Benefits	N/A
Gross Profit	8.25 Billion
Ebitda	3.34 Billion
Source	edgar
Ebit	3.21 Billion

GE HealthCare Technologies Inc. Annual Reports (10-K)